ÂÜÀòÂÒÂ×

Ira Wallace is an experienced angel investor and managing director with a robust background in life sciences and technology commercialization. Currently serving as an angel investor for Broad Street Angels, Mid Atlantic Bio Angels, and Keiretsu Forum, Wallace also holds the position of managing director at WAN Advisory, guiding startups through complex business strategies from conception to exit. Previous roles include chief development officer at NovoBioPharma, where advisory services were provided to life science organizations, and CEO of EyeIC, Inc., a software-based medical device company. A vice president at Walter Greenblatt & Associates, Wallace specializes in bridging science and investment, while also contributing expertise at CapGenic Advisors across various industries. Educational credentials include an MBA from Columbia Business School, an MD from Drexel University College of Medicine, and a BA from the University of Pennsylvania.